Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia
Not yet recruiting · NCT06684509 · Registry updated 2024-11-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, hematologic disorder, immune system disorder, immunoproliferative disorder, injury, leukemia, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, radiation injury | Not yet recruiting | Phase 1 / Phase 2 | 2024-11-12 | NCT06684509 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assiut University | 1477 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Assiut University | Asyut | Egypt | 12 |